No more promethazine in kids under two, warns FDA
An FDA alert has been issued to warn practitioners that allproducts containing promethazine HCl are now contraindicated inchildren younger than two years of age. The labeling change comesafter the agency received reports of respiratory depression anddeath following use of the drug by children in this age group.
An FDA alert has been issued to warn practitioners that all products containing promethazine HCl are now contraindicated in children younger than two years of age. The labeling change comes after the agency received reports of respiratory depression and death following use of the drug by children in this age group. In addition, the alert warns that caution should be used when administering promethazine HCl medications to pediatric patients two years of age and older. The warning was issued for all brands and formulations, including syrups, tablets, injectables, and suppositories.
To see more Hot off the Press news articles, click here http://www.drugtopics.com/Hot+off+the+Press.
To go to the Drug Topics homepage, click here http://www.drugtopics.com.
FDA’s Recent Exemptions: What Do They Mean as We Finalize DSCSA Implementation?
October 31st 2024Kala Shankle, Vice President of Regulatory Affairs with the Healthcare Distribution Alliance, and Ilisa Bernstein, President of Bernstein Rx Solutions, LLC, discussed recent developments regarding the Drug Supply Chain Security Act.
